Literature DB >> 31696505

Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities.

Meghan J Chenoweth1,2, Kathleen M Giacomini3, Munir Pirmohamed4, Susan L Hill5, Ron H N van Schaik6, Matthias Schwab7,8,9, Alan R Shuldiner10,11, Mary V Relling12, Rachel F Tyndale1,2,13.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31696505      PMCID: PMC7077926          DOI: 10.1002/cpt.1664

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  10 in total

1.  Educational innovations in clinical pharmacogenomics.

Authors:  C G Perry; K A Maloney; A L Beitelshees; Ljb Jeng; N P Ambulos; A R Shuldiner; M G Blitzer
Journal:  Clin Pharmacol Ther       Date:  2016-04-07       Impact factor: 6.875

Review 2.  Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).

Authors:  Thomas O Bergmeijer; Jean-Luc Reny; Ruth E Pakyz; Li Gong; Joshua P Lewis; Eun-Young Kim; Daniel Aradi; Israel Fernandez-Cadenas; Richard B Horenstein; Ming Ta Michael Lee; Ryan M Whaley; Joan Montaner; Gian Franco Gensini; John H Cleator; Kiyuk Chang; Lene Holmvang; Willibald Hochholzer; Dan M Roden; Stefan Winter; Russ B Altman; Dimitrios Alexopoulos; Ho-Sook Kim; Jean-Pierre Déry; Meinrad Gawaz; Kevin Bliden; Marco Valgimigli; Rossella Marcucci; Gianluca Campo; Elke Schaeffeler; Nadia P Dridi; Ming-Shien Wen; Jae Gook Shin; Tabassome Simon; Pierre Fontana; Betti Giusti; Tobias Geisler; Michiaki Kubo; Dietmar Trenk; Jolanta M Siller-Matula; Jurriën M Ten Berg; Paul A Gurbel; Jean-Sebastien Hulot; Braxton D Mitchell; Matthias Schwab; Marylyn DeRiggi Ritchie; Teri E Klein; Alan R Shuldiner
Journal:  Am Heart J       Date:  2017-12-17       Impact factor: 4.749

Review 3.  Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium.

Authors:  Xiaoyan Chu; Mingxiang Liao; Hong Shen; Kenta Yoshida; Arik A Zur; Vikram Arya; Aleksandra Galetin; Kathleen M Giacomini; Imad Hanna; Hiroyuki Kusuhara; Yurong Lai; David Rodrigues; Yuichi Sugiyama; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Clin Pharmacol Ther       Date:  2018-11       Impact factor: 6.875

4.  The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients.

Authors:  Marzia Del Re; Elisa Biasco; Stefania Crucitta; Lisa Derosa; Eleonora Rofi; Cinzia Orlandini; Mario Miccoli; Luca Galli; Alfredo Falcone; Guido W Jenster; Ron H van Schaik; Romano Danesi
Journal:  Eur Urol       Date:  2016-10-10       Impact factor: 20.096

Review 5.  Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.

Authors:  Simona Volpi; Carol J Bult; Rex L Chisholm; Patricia A Deverka; Geoffrey S Ginsburg; Howard J Jacob; Melpomeni Kasapi; Howard L McLeod; Dan M Roden; Marc S Williams; Eric D Green; Laura Lyman Rodriguez; Samuel Aronson; Larisa H Cavallari; Joshua C Denny; Lynn G Dressler; Julie A Johnson; Teri E Klein; J Steven Leeder; Micheline Piquette-Miller; Minoli Perera; Laura J Rasmussen-Torvik; Heidi L Rehm; Marylyn D Ritchie; Todd C Skaar; Nikhil Wagle; Richard Weinshilboum; Kristin W Weitzel; Robert Wildin; John Wilson; Teri A Manolio; Mary V Relling
Journal:  Clin Pharmacol Ther       Date:  2018-03-30       Impact factor: 6.875

6.  Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response.

Authors:  Joshua D Backman; Jeffrey R O'Connell; Keith Tanner; Cody J Peer; William D Figg; Shawn D Spencer; Braxton D Mitchell; Alan R Shuldiner; Laura M Yerges-Armstrong; Richard B Horenstein; Joshua P Lewis
Journal:  Pharmacogenet Genomics       Date:  2017-04       Impact factor: 2.089

7.  DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.

Authors:  Linda M Henricks; Carin A T C Lunenburg; Femke M de Man; Didier Meulendijks; Geert W J Frederix; Emma Kienhuis; Geert-Jan Creemers; Arnold Baars; Vincent O Dezentjé; Alexander L T Imholz; Frank J F Jeurissen; Johanna E A Portielje; Rob L H Jansen; Paul Hamberg; Albert J Ten Tije; Helga J Droogendijk; Miriam Koopman; Peter Nieboer; Marlène H W van de Poel; Caroline M P W Mandigers; Hilde Rosing; Jos H Beijnen; Erik van Werkhoven; André B P van Kuilenburg; Ron H N van Schaik; Ron H J Mathijssen; Jesse J Swen; Hans Gelderblom; Annemieke Cats; Henk-Jan Guchelaar; Jan H M Schellens
Journal:  Lancet Oncol       Date:  2018-10-19       Impact factor: 41.316

8.  The 100 000 Genomes Project: bringing whole genome sequencing to the NHS.

Authors:  Clare Turnbull; Richard H Scott; Ellen Thomas; Louise Jones; Nirupa Murugaesu; Freya Boardman Pretty; Dina Halai; Emma Baple; Clare Craig; Angela Hamblin; Shirley Henderson; Christine Patch; Amanda O'Neill; Katherine Smith; Antonio Rueda Martin; Alona Sosinsky; Ellen M McDonagh; Razvan Sultana; Michael Mueller; Damian Smedley; Adam Toms; Lisa Dinh; Tom Fowler; Mark Bale; Tim Hubbard; Augusto Rendon; Sue Hill; Mark J Caulfield
Journal:  BMJ       Date:  2018-04-24

9.  Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.

Authors:  W S Bush; D R Crosslin; A Owusu-Obeng; J Wallace; B Almoguera; M A Basford; S J Bielinski; D S Carrell; J J Connolly; D Crawford; K F Doheny; C J Gallego; A S Gordon; B Keating; J Kirby; T Kitchner; S Manzi; A R Mejia; V Pan; C L Perry; J F Peterson; C A Prows; J Ralston; S A Scott; A Scrol; M Smith; S C Stallings; T Veldhuizen; W Wolf; S Volpi; K Wiley; R Li; T Manolio; E Bottinger; M H Brilliant; D Carey; R L Chisholm; C G Chute; J L Haines; H Hakonarson; J B Harley; I A Holm; I J Kullo; G P Jarvik; E B Larson; C A McCarty; M S Williams; J C Denny; L J Rasmussen-Torvik; D M Roden; M D Ritchie
Journal:  Clin Pharmacol Ther       Date:  2016-06-01       Impact factor: 6.875

10.  Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study.

Authors:  Andrea L Jorgensen; Clare Prince; Gail Fitzgerald; Anita Hanson; Jennifer Downing; Julia Reynolds; J Eunice Zhang; Ana Alfirevic; Munir Pirmohamed
Journal:  BMC Med       Date:  2019-04-08       Impact factor: 8.775

  10 in total
  11 in total

1.  Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.

Authors:  Kathleen M Giacomini; Jason H Karnes; Kristine R Crews; Andrew A Monte; William A Murphy; Akinyemi Oni-Orisan; Laura B Ramsey; Jun J Yang; Michelle Whirl-Carrillo
Journal:  Clin Pharmacol Ther       Date:  2021-07-28       Impact factor: 6.875

2.  Pharmacogenomics and Personalized Medicine.

Authors:  Erika Cecchin; Gabriele Stocco
Journal:  Genes (Basel)       Date:  2020-06-22       Impact factor: 4.096

Review 3.  Drug Design: Where We Are and Future Prospects.

Authors:  Giuseppe Zagotto; Marco Bortoli
Journal:  Molecules       Date:  2021-11-22       Impact factor: 4.411

Review 4.  From pharmacogenetics to pharmaco-omics: Milestones and future directions.

Authors:  Chiara Auwerx; Marie C Sadler; Alexandre Reymond; Zoltán Kutalik
Journal:  HGG Adv       Date:  2022-03-16

Review 5.  Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG).

Authors:  Karina Bienfait; Aparna Chhibber; Jean-Claude Marshall; Martin Armstrong; Charles Cox; Peter M Shaw; Charles Paulding
Journal:  Hum Genet       Date:  2021-06-03       Impact factor: 5.881

6.  A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting.

Authors:  Céline K Stäuble; Chiara Jeiziner; Anna Bollinger; Florine M Wiss; Martin Hatzinger; Kurt E Hersberger; Thomas Ihde; Markus L Lampert; Thorsten Mikoteit; Henriette E Meyer Zu Schwabedissen; Samuel S Allemann
Journal:  Pharmacy (Basel)       Date:  2022-07-19

Review 7.  Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis.

Authors:  Sung Ho Lim; Khangyoo Kim; Chang-Ik Choi
Journal:  J Pers Med       Date:  2022-07-31

Review 8.  Pharmacogenomic testing in paediatrics: Clinical implementation strategies.

Authors:  Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716

Review 9.  Cancer drug resistance induced by EMT: novel therapeutic strategies.

Authors:  Javier De Las Rivas; Anamaria Brozovic; Sivan Izraely; Alba Casas-Pais; Isaac P Witz; Angélica Figueroa
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

10.  Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study.

Authors:  George Astras; Christos I Papagiannopoulos; Konstantinos A Kyritsis; Constantina Markitani; Ioannis S Vizirianakis
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.